RBM15B and hepatocellular carcinoma: These results claim that, in HCC, FARSB may have a close relation with the m6A modification, specifically via its interactions with LRPPRC, RBM15B, and HNRNPA2B1, all of which eventually influence the progression and prognosis of HCC.